Education
About Us
Working with TipRanks
Follow Us
Jack Nathan Medical (JNHMF)
OTHER OTC:JNHMF
Total Valuation
Jack Nathan Medical has a market cap or net worth of $302.03K. The enterprise value is -$182.84K.
Market Cap$302.03K
Enterprise Value-$182.84K
Share Statistics
Jack Nathan Medical has 41,349,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,349,160
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jack Nathan Medical’s return on equity (ROE) is 5.64 and return on invested capital (ROIC) is -128.16%.
Return on Equity (ROE)5.64
Return on Assets (ROA)2.11
Return on Invested Capital (ROIC)-128.16%
Return on Capital Employed (ROCE)-1.36
Revenue Per Employee362.77K
Profits Per Employee311.03K
Employee Count24
Asset Turnover2.46
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Jack Nathan Medical is ―. Jack Nathan Medical’s PEG ratio is -0.02.
PE Ratio―
PS Ratio0.86
PB Ratio5.64
Price to Fair Value5.64
Price to FCF-0.99
Price to Operating Cash Flow-0.03
PEG Ratio-0.02
Income Statement
In the last 12 months, Jack Nathan Medical had revenue of 8.71M and earned 7.46M in profits. Earnings per share was -0.03.
Revenue8.71M
Gross Profit7.37M
Operating Income-2.48M
Pretax Income-2.51M
Net Income7.46M
EBITDA-1.54M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -4.73M and capital expenditures -618.45K, giving a free cash flow of -5.34M billion.
Operating Cash Flow-4.73M
Free Cash Flow-5.34M
Free Cash Flow per Share-0.13
Dividends & Yields
Jack Nathan Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.34
52-Week Price Change-43.33%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)62.07
Average Volume (3m)500.00
Important Dates
Jack Nathan Medical upcoming earnings date is Jun 3, 2026, After Close (Confirmed).
Last Earnings DateJan 6, 2026
Next Earnings DateJun 3, 2026
Ex-Dividend Date―
Financial Position
Jack Nathan Medical as a current ratio of 1.81, with Debt / Equity ratio of 229.83%
Current Ratio1.81
Quick Ratio1.81
Debt to Market Cap<0.01
Net Debt to EBITDA1.27
Interest Coverage Ratio-39.03
Taxes
In the past 12 months, Jack Nathan Medical has paid 16.35K in taxes.
Income Tax16.35K
Effective Tax Rate>-0.01
Enterprise Valuation
Jack Nathan Medical EV to EBITDA ratio is -3.58, with an EV/FCF ratio of -0.73.
EV to Sales0.63
EV to EBITDA-3.58
EV to Free Cash Flow-0.73
EV to Operating Cash Flow-0.87
Balance Sheet
Jack Nathan Medical has $802.39K in cash and marketable securities with $206.06K in debt, giving a net cash position of $596.33K billion.
Cash & Marketable Securities$802.39K
Total Debt$206.06K
Net Cash$596.33K
Net Cash Per Share$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 87.38%, with operating margin of -28.48%, and net profit margin of 85.74%.
Gross Margin87.38%
Operating Margin-28.48%
Pretax Margin-28.88%
Net Profit Margin85.74%
EBITDA Margin-17.68%
EBIT Margin-27.45%
Analyst Forecast
The average price target for Jack Nathan Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―